BR0013793A - Medicamentos profiláticos e terapêuticos para doenças oftálmicas - Google Patents

Medicamentos profiláticos e terapêuticos para doenças oftálmicas

Info

Publication number
BR0013793A
BR0013793A BR0013793-6A BR0013793A BR0013793A BR 0013793 A BR0013793 A BR 0013793A BR 0013793 A BR0013793 A BR 0013793A BR 0013793 A BR0013793 A BR 0013793A
Authority
BR
Brazil
Prior art keywords
prophylactic
therapeutic drugs
diseases
ophthalmic diseases
ophthalmic
Prior art date
Application number
BR0013793-6A
Other languages
English (en)
Inventor
Hiroaki Naka
Kazuhito Kawabata
Hideki Tokushige
Original Assignee
Ono Pharmaceutical Co
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co, Senju Pharma Co filed Critical Ono Pharmaceutical Co
Publication of BR0013793A publication Critical patent/BR0013793A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "MEDICAMENTOS PROFILáTICOS E TERAPêUTICOS PARA DOENçAS OFTáLMICAS". A presente invenção fornece um medicamento profilático e terapêutico para doenças oftálmicas, especialmente doenças inflamatórias oftálmicas e úlcera da córnea, compreendendo como um ingrediente ativo um composto representado pela fórmula (I): ou um sal farmacologicamente aceitável ou hidrato disso.
BR0013793-6A 1999-09-06 2000-09-05 Medicamentos profiláticos e terapêuticos para doenças oftálmicas BR0013793A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25153899 1999-09-06
PCT/JP2000/006014 WO2001017527A1 (en) 1999-09-06 2000-09-05 Preventive and therapeutic agents for eye diseases

Publications (1)

Publication Number Publication Date
BR0013793A true BR0013793A (pt) 2002-05-14

Family

ID=17224318

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013793-6A BR0013793A (pt) 1999-09-06 2000-09-05 Medicamentos profiláticos e terapêuticos para doenças oftálmicas

Country Status (14)

Country Link
US (1) US6624193B1 (pt)
EP (1) EP1213018A4 (pt)
JP (1) JP4682495B2 (pt)
KR (1) KR20020042667A (pt)
CN (1) CN1387436A (pt)
AU (1) AU6870800A (pt)
BR (1) BR0013793A (pt)
CA (1) CA2383971A1 (pt)
HU (1) HUP0202745A2 (pt)
MX (1) MXPA02002452A (pt)
NO (1) NO20021094L (pt)
NZ (1) NZ517556A (pt)
WO (1) WO2001017527A1 (pt)
ZA (1) ZA200201819B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552082B2 (en) * 2000-06-29 2003-04-22 Ono Pharmaceutical Co., Ltd. Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
ES2396598T3 (es) * 2000-08-25 2013-02-22 Senju Pharmaceutical Co., Ltd. Preparaciones en forma de suspensiones acuosas
US7315848B2 (en) * 2001-12-12 2008-01-01 Aaron Pearse Web snippets capture, storage and retrieval system and method
US8129431B2 (en) 2003-01-21 2012-03-06 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
US8372814B2 (en) * 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US8748402B2 (en) 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
JPWO2006087968A1 (ja) * 2005-02-17 2008-07-03 角治 東條 眼科用固形外用薬剤
BRPI0718374A2 (pt) * 2006-09-29 2013-06-25 Johnson & Johnson Vision Care mÉtodos e dispositivos oftÁlmicos usados no tratamento de alergias oculares
CN101674807B (zh) * 2007-05-04 2013-03-20 博士伦公司 用于缓解、改善、治疗或预防干眼症的组合物及其制备和使用方法
KR20100016285A (ko) * 2007-05-07 2010-02-12 보오슈 앤드 롬 인코포레이팃드 안구건조 상태를 감소, 개선, 치료 또는 예방하기 위한 조성물 및 이의 제조 및 사용 방법
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
CN102340993A (zh) * 2009-03-03 2012-02-01 爱尔康研究有限公司 向眼部递送受体酪氨酸激酶抑制性(RTKi)化合物的药物组合物
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
KR102433489B1 (ko) 2013-03-14 2022-08-17 팬옵티카, 인크. 눈의 후안부로의 약물 전달을 위한 안구용 제제
EP3310361B1 (en) 2015-06-16 2022-05-11 Wu, Rong-Tsun Method for treating or preventing dry eyes
WO2019005222A1 (en) * 2017-06-29 2019-01-03 Advaite LLC. TREATMENT AND DIAGNOSIS OF OCULAR SURFACE DISORDERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017610A (en) * 1988-06-13 1991-05-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-substituted phenyl ester of pivalic acid
JPH0320253A (ja) * 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
WO1990004409A1 (en) 1988-10-27 1990-05-03 University Of Kentucky Research Foundation Human leukocyte elastase inhibitors and methods of producing and using same
DE69223455T2 (de) 1991-06-18 1998-04-02 Fujisawa Pharmaceutical Co WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
GB9115811D0 (en) 1991-07-22 1991-09-04 Fujisawa Pharmaceutical Co Fr901451 substance,process for preparation thereof and use thereof
EP0539223A1 (en) 1991-10-25 1993-04-28 Ono Pharmaceutical Co., Ltd. Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
JPH05194366A (ja) * 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法

Also Published As

Publication number Publication date
EP1213018A1 (en) 2002-06-12
ZA200201819B (en) 2003-05-28
WO2001017527A1 (en) 2001-03-15
AU6870800A (en) 2001-04-10
NZ517556A (en) 2003-08-29
KR20020042667A (ko) 2002-06-05
NO20021094L (no) 2002-05-06
NO20021094D0 (no) 2002-03-05
WO2001017527A9 (fr) 2001-06-21
JP4682495B2 (ja) 2011-05-11
EP1213018A4 (en) 2004-04-14
CA2383971A1 (en) 2001-03-15
CN1387436A (zh) 2002-12-25
MXPA02002452A (es) 2004-09-10
US6624193B1 (en) 2003-09-23
HUP0202745A2 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
NO20045656L (no) Oftalmologisk anvendelse av roflumilast for behandlingen av oyesykdommer
DE60128258D1 (de) Indanylderivate zur Behandlung von Atemwegserkrankungen
NO950297D0 (no) Prolinamidderivater
BRPI0509863A (pt) liberação de fármaco para fundo de olho
SE9901573D0 (sv) New compounds
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
SE0102440D0 (sv) New compound
EP1228758A4 (en) PROHYLACTIC AND THERAPEUTIC AGENTS FOR INFLAMMABLE COLON DISEASES
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
EP1426360A4 (en) 2-PHENYL-3-HETEROARYLPROPIONIC ACID DERIVATIVE OR SALT THEREOF AND MEDICAMENTS CONTAINING THE SAME
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
SE9901572D0 (sv) New compounds
MXPA05014143A (es) Derivados de cumarina para el tratamiento de trastornos oftalmicos.
EP1062948A4 (en) DRUGS AGAINST CARDIAC DIASTOLIC DISORDERS
BR0009327A (pt) Composição farmacêutica para a terapia de sintomas do trato urinário inferior
NZ542305A (en) Treatment of proliferative diseases with an epothilone derivative and radiation
MXPA05008883A (es) Agente terapeutico para enfermedad hemorroidal.
BR0207307A (pt) Inibidores de glyt-1
HUP0301334A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és taxánokat és/vagy antimetabolitokat tartalmazó kombinált tumorellenes kompozíciók
NO993911L (no) Remedier/Forebygningsmidler for Õndedrettssykdommer

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.